Department of Psychiatry, Epidemiology of Psychiatric Disorders and Mental Health Research Unit, Faculty of Medicine, Chulalongkorn University, Pathumwan, Bangkok, 10330, Thailand.
Department of Psychiatry, King Chulalongkorn Memorial Hospital, Pathumwan, Bangkok, 10330, Thailand.
BMC Public Health. 2023 May 19;23(1):911. doi: 10.1186/s12889-023-15883-6.
Thailand was the first country in Asia to legalize the use and purchase of cannabis leaves in February 2021 and the whole plant in June 2022 after the 2019 allowance for medical purposes. The study explored trends in cannabis use in Thailand before and after the recreational cannabis allowance was imposed.
Cannabis and other variables of substance use, cannabis use disorder, and attitude towards cannabis of the Thai population aged 18 to 65 years in 2019 (n = 5,002), 2020 (n = 5,389) and 2021 (n = 5,669) were obtained from annual surveys conducted in the last two months of each year by the Centre for Addiction Studies. The surveys were repeat cross-sectional surveys of the general population of Thailand. Repeated variables from at least two annual surveys were included for analysis using the Chi-square test and the t-test.
The prevalence of cannabis use in the past year had increased from 2.2% in 2019 to 2.5% and 4.2% in 2020 and 2021 respectively, while those of methamphetamine, alcohol, and tobacco use had decreased. Trends in past-year drinking/eating cannabis products had increased, especially among the middle age group (40-49 years) from 2.1% (95% confidence interval (CI): 1.3, 3.1) in 2019 and 1.1% (95% CI: 0.6, 1.9) in 2020 to 3.8% (95% CI: 2.8, 5.0) in 2021. The younger population aged 18-19 had an increase in cannabis smoking from 0.9% (95% CI: 0.1, 3.3) in 2019 to 2.0% (95% CI: 0.5, 5.1) and 2.2% (95% CI: 0.7, 5.1) in 2020 and 2021 respectively. Symptoms of cannabis use disorder among cannabis users increased from 2019 to 2020 and then reversed afterwards in 2021. Thais had greater health knowledge about the benefits and harms of cannabis and had attitudes toward more harm of cannabis in 2021; however, 35.6% or a third of the sample in 2021 truly believed that cannabis was a cure for cancer, and 23.2% or one-fourth were uncertain or did not believe that cannabis was addictive.
Although most of the substances had a lower prevalence of use during the COVID-19 pandemic in Thailand, cannabis had a higher use after legalization. Thai youth had a growing trend to smoke cannabis.
泰国是亚洲第一个在 2019 年允许医用大麻使用和购买后,于 2021 年 2 月合法化大麻叶使用,并于 2022 年 6 月合法化整株大麻使用的国家。本研究探讨了泰国在娱乐性大麻合法化前后大麻使用趋势的变化。
2019 年(n=5002)、2020 年(n=5389)和 2021 年(n=5669),从成瘾研究中心在每年最后两个月进行的年度调查中获取了年龄在 18 至 65 岁的泰国人口的大麻和其他物质使用、大麻使用障碍以及对大麻的态度等变量。这些调查是对泰国一般人群进行的重复横断面调查。使用卡方检验和 t 检验,对至少两个年度调查中的重复变量进行分析。
过去一年大麻使用的流行率从 2019 年的 2.2%分别上升到 2020 年的 2.5%和 2021 年的 4.2%,而冰毒、酒精和烟草的使用流行率则下降。过去一年吸食/食用大麻制品的趋势有所增加,尤其是在中年人群(40-49 岁)中,从 2019 年的 2.1%(95%置信区间(CI):1.3,3.1)和 2020 年的 1.1%(95% CI:0.6,1.9)增加到 2021 年的 3.8%(95% CI:2.8,5.0)。18-19 岁的年轻人群中,大麻吸食的流行率从 2019 年的 0.9%(95% CI:0.1,3.3)增加到 2020 年的 2.0%(95% CI:0.5,5.1)和 2021 年的 2.2%(95% CI:0.7,5.1)。大麻使用者的大麻使用障碍症状从 2019 年到 2020 年增加,然后在 2021 年逆转。泰国人对大麻的益处和危害有更多的健康知识,并且对大麻的危害持更严厉的态度;然而,2021 年有 35.6%或三分之一的样本确实认为大麻是治疗癌症的良药,而 23.2%或四分之一的人不确定或不认为大麻会上瘾。
尽管在泰国 COVID-19 大流行期间,大多数物质的使用流行率较低,但大麻合法化后使用量增加。泰国青年吸食大麻的趋势不断增长。